Element Materials Technology (Element) has signed an agreement to acquire JMI Laboratories based in North Liberty, IA, further strengthening Element’s offering for pharmaceutical and biopharmaceutical customers in North America and beyond.     JMI is a market leader in antimicrobial resistance monitoring studies used for U.S. FDA regulatory and new drug application submissions, through their SENTRY Antimicrobial Surveillance Program. It offers microbiology and molecular testing services to ass...